Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma

Por Lisenko, K., Dingeldein, G., Cremer, M., Kriegsmann, M., Ho, A. D., Rieger, M., Witzens-Harig, M.
Publicado no BMC Cancer (2017)

Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma

Por Lisenko, K., McClanahan, F., Schöning, T., Schwarzbich, M. A., Cremer, M., Dittrich, T., Ho, A. D., Witzens-Harig, M.
Publicado no BMC Cancer (2016)